Image source: The Motley Fool.
Atara Biotherapeutics Inc (NASDAQ: ATRA)
Q3 2020 Earnings Call
Nov 9, 2020 , 4:30 p.m. ET
Operator
For further details see:
Atara Biotherapeutics Inc (ATRA) Q3 2020 Earnings Call TranscriptImage source: The Motley Fool.
Atara Biotherapeutics Inc (NASDAQ: ATRA)
Q3 2020 Earnings Call
Nov 9, 2020 , 4:30 p.m. ET
Operator
For further details see:
Atara Biotherapeutics Inc (ATRA) Q3 2020 Earnings Call TranscriptMarket Wire News is a media platform, the information on this page was provided by Motley Fool via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Atara Biotherapeutics Inc. Company Name:
ATRA Stock Symbol:
Market:
Atara Biotherapeutics Inc. Website:
Tab-cel ® U.S. BLA on Track for Submission in Q2 2024 Initiation of ATA3219 Lupus Nephritis Study Expected in Q4 2024, with Initial Clinical Data Expected in H1 2025 Initiation of New ATA3219 Cohort Without Lymphodepletion in Severe Systemic Lupus Erythematosus Planned fo...
Tab-cel ® U.S. BLA on Track for Submission in Q2 2024 Following Positive Pre-BLA Meeting Allogeneic CAR T Pipeline Expands Into Autoimmune Disease With Plans to Initiate an ATA3219 Lupus Nephritis Study in H2 2024, and Initial Clinical Data Expected H1 2025 AT...